Vanhove B - Search Results

1

[Next generation of anti-immune checkpoints antibodies].

Bonnefoy N, Olive D, Vanhove B. Bonnefoy N, et al. Among authors: vanhove b. Med Sci (Paris). 2019 Dec;35(12):966-974. doi: 10.1051/medsci/2019193. Epub 2020 Jan 6. Med Sci (Paris). 2019. PMID: 31903901 Free article. Review. French.

2

Differential effect of CD28 versus B7 blockade on direct pathway of allorecognition and self-restricted responses.

Haspot F, Villemain F, Laflamme G, Coulon F, Olive D, Tiollier J, Soulillou JP, Vanhove B. Haspot F, et al. Among authors: vanhove b. Blood. 2002 Mar 15;99(6):2228-34. doi: 10.1182/blood.v99.6.2228. Blood. 2002. PMID: 11877302 Free article.

3

Risk in drug trials.

Ohresser M, Olive D, Vanhove B, Watier H. Ohresser M, et al. Among authors: vanhove b. Lancet. 2006 Dec 23;368(9554):2205-6. doi: 10.1016/S0140-6736(06)69883-8. Lancet. 2006. PMID: 17189022 No abstract available.

4

[Monoclonal antibodies in organ transplantation].

Vanhove B. Vanhove B. Med Sci (Paris). 2009 Dec;25(12):1121-5. doi: 10.1051/medsci/200925121121. Med Sci (Paris). 2009. PMID: 20035690 Free article. Review. French.

5

[On the acceptability of xenografts].

Séveno C, Fellous M, Ashton-Chess J, Soulillou JP, Vanhove B. Séveno C, et al. Among authors: vanhove b. Med Sci (Paris). 2005 Mar;21(3):302-8. doi: 10.1051/medsci/2005213302. Med Sci (Paris). 2005. PMID: 15745706 Free article. Review. French.

6

Anti-CD28 antibodies modify regulatory mechanisms and reinforce tolerance in CD40Ig-treated heart allograft recipients.

Guillonneau C, Séveno C, Dugast AS, Li XL, Renaudin K, Haspot F, Usal C, Veziers J, Anegon I, Vanhove B. Guillonneau C, et al. Among authors: vanhove b. J Immunol. 2007 Dec 15;179(12):8164-71. doi: 10.4049/jimmunol.179.12.8164. J Immunol. 2007. PMID: 18056359

7

Antagonist properties of monoclonal antibodies targeting human CD28: role of valency and the heavy-chain constant domain.

Mary C, Coulon F, Poirier N, Dilek N, Martinet B, Blancho G, Vanhove B. Mary C, et al. Among authors: vanhove b. MAbs. 2013 Jan-Feb;5(1):47-55. doi: 10.4161/mabs.22697. Epub 2012 Dec 5. MAbs. 2013. PMID: 23221503 Free PMC article.

8

Targeting CD28, CTLA-4 and PD-L1 costimulation differentially controls immune synapses and function of human regulatory and conventional T-cells.

Dilek N, Poirier N, Hulin P, Coulon F, Mary C, Ville S, Vie H, Clémenceau B, Blancho G, Vanhove B. Dilek N, et al. Among authors: vanhove b. PLoS One. 2013 Dec 23;8(12):e83139. doi: 10.1371/journal.pone.0083139. eCollection 2013. PLoS One. 2013. PMID: 24376655 Free PMC article.

9

Dynamic human immune and tumour cells cross-talk in PDX-humanised mice warrants checkpoint inhibitor cancer immunotherapies assessment.

Poirier N, Vanhove B. Poirier N, et al. Among authors: vanhove b. Gut. 2018 Oct;67(10):1753-1754. doi: 10.1136/gutjnl-2018-316467. Epub 2018 Apr 26. Gut. 2018. PMID: 29700013 No abstract available.

10

IL-7 receptor blockade blunts antigen-specific memory T cell responses and chronic inflammation in primates.

Belarif L, Mary C, Jacquemont L, Mai HL, Danger R, Hervouet J, Minault D, Thepenier V, Nerrière-Daguin V, Nguyen E, Pengam S, Largy E, Delobel A, Martinet B, Le Bas-Bernardet S, Brouard S, Soulillou JP, Degauque N, Blancho G, Vanhove B, Poirier N. Belarif L, et al. Among authors: vanhove b. Nat Commun. 2018 Oct 26;9(1):4483. doi: 10.1038/s41467-018-06804-y. Nat Commun. 2018. PMID: 30367166 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

126 results

Search Page